GILUPI GmbH, headquartered in Germany, is a pioneering company in the field of medical technology, specialising in innovative solutions for cancer diagnostics. Founded in 2006, GILUPI has made significant strides in the industry, particularly with its flagship product, the GILUPI CellCollector, which enables the capture of circulating tumour cells (CTCs) from blood samples. This unique technology enhances early cancer detection and monitoring, setting GILUPI apart in the competitive landscape of oncology diagnostics. With a strong presence in Europe and expanding operations globally, GILUPI is recognised for its commitment to advancing personalised medicine. The company has achieved notable milestones, including collaborations with leading research institutions, further solidifying its position as a key player in the medical technology sector. GILUPI continues to drive innovation, aiming to improve patient outcomes through its cutting-edge diagnostic solutions.
We don't have data for GILUPI GmbH, but we can show you information about their parent organization instead.
View parent company